Medical Equipment

Global Balloon Valvuloplasty Device Industry Trends and Market Growth Forecast for 2026–2030

March 10, 2026March 10, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Large Is The Balloon Valvuloplasty Device Market Projected To Become By 2030 Based On Its 2026 Valuation?

The market for balloon valvuloplasty devices has experienced substantial expansion over recent years. This market is projected to expand from $2.57 billion in 2025 to $2.73 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 5.9%. Historically, this growth was driven by factors such as the increasing prevalence of cardiac valve stenosis, the rapid adoption of minimally invasive interventional cardiology procedures, advancements in standard and compliant balloon technologies, the proliferation of hospital-based cardiac catheterization laboratories, and the rising number of treatments for pediatric congenital heart conditions.

The balloon valvuloplasty device market is anticipated to experience robust growth in the upcoming years. It is forecast to grow to $3.35 billion in 2030, achieving a compound annual growth rate (CAGR) of 5.3%. This projected growth can be attributed to an expanding aging population affected by aortic and mitral valve stenosis, a rising demand for high-pressure and scoring balloon devices, the broader application of balloon valvuloplasty in ambulatory and specialty clinics, an increasing move towards non-surgical cardiac treatment pathways, and ongoing innovation in balloon materials and device design. Major trends observed during the forecast period include a growing preference for minimally invasive valve repair procedures, the increasing adoption of balloon valvuloplasty as an alternative to open-heart surgery, expanding utilization in pediatric and adult congenital heart valve disorders, the proliferation of valve dilation procedures in specialty cardiology centers, and a focus on improving patient outcomes and reducing recovery times.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=17090&type=smp

What Major Growth Drivers Are Shaping The Outlook Of The Balloon Valvuloplasty Device Market?

The increasing preference for minimally invasive procedures is projected to boost the expansion of the balloon valvuloplasty device market in the future. These procedures refer to medical techniques performed through small incisions or natural body openings, leading to less trauma and facilitating quicker recovery compared to conventional surgeries. The heightened demand for minimally invasive procedures stems from their reduced recuperation times, lower risk of complications, and diminished post-operative pain when contrasted with traditional surgical methods. Balloon valvuloplasty devices are utilized in minimally invasive surgical interventions to widen narrowed heart valves, improve blood flow, and lessen symptoms. For instance, in January 2024, Intuitive Surgical Inc., a US-based manufacturer of robotic products, disclosed that they had deployed 415 da Vinci surgical systems (robotic surgical systems that employ a minimally invasive surgical approach) in the fourth quarter of 2023, which signifies a 12% increase compared to 2022. Thus, the growing inclination towards minimally invasive procedures is a significant force driving the growth of the balloon valvuloplasty device market.

What Segment Groups Are Identified Within The Balloon Valvuloplasty Device Market?

The balloon valvuloplasty device market covered in this report is segmented –

1) By Product Type: Standard Balloon, Cutting Balloon, Scoring Balloon, High-Pressure Balloon, Low-Pressure Balloon

2) By Age Group: Pediatric, Adult

3) By End-use: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Other End Uses

Subsegments:

1) By Standard Balloon: Non-Compliant Balloons, Compliant Balloons

2) By Cutting Balloon: Single-Cutting Balloon, Multi-Cutting Balloon

3) By Scoring Balloon: Single-Score Balloons, Dual-Score Balloons

4) By High-Pressure Balloon: Non-Compliant High-Pressure Balloons, Compliant High-Pressure Balloons

5) By Low-Pressure Balloon: Semi-Compliant Low-Pressure Balloons, Non-Compliant Low-Pressure Balloons

What Trends Are Advancing Progress In The Balloon Valvuloplasty Device Market?

Leading companies in the balloon valvuloplasty device market are focusing on developing advanced products, such as Pacing Guidewires, to gain a competitive edge. This specialized wire provides temporary cardiac pacing during the procedure, ensuring the heart maintains a stable rhythm while the balloon catheter is inserted and inflated to dilate the narrowed valve. For instance, in June 2023, Teleflex Incorporated, a US-based medical device company, received clearance from the Food and Drug Administration (FDA) for the Wattson Temporary Pacing Guidewire. This new device is specifically designed for use during transcatheter aortic valve replacement (TAVR) and balloon aortic valvuloplasty (BAV) procedures. The Wattson Temporary Pacing Guidewire offers dual functionality, supporting both valve delivery and ventricular bipolar pacing during these structural heart procedures. Its flexible distal pigtail shape, multiple electrodes, and bipolar design are engineered to help reduce the risk of ventricular perforation while providing reliable electrical capture during rapid pacing.

Which Companies Hold Significant Positions In The Balloon Valvuloplasty Device Market?

Major companies operating in the balloon valvuloplasty device market are Boston Scientific Corporation, Medtronic plc, Abbott Laboratories, Edwards Lifesciences Corporation, Terumo Corporation, B Braun Melsungen AG, Cook Medical Incorporated, Balton Sp z o o, Meril Life Sciences Pvt Ltd, JenaValve Technology Inc, Osypka Medical GmbH, Scitech Medical, Translumina GmbH, AndraTec GmbH, Palex Medical SA, Biosensors International Group Ltd, Hexacath, MicroPort Scientific Corporation, Lepu Medical Technology Beijing Co Ltd, QT Vascular Ltd

Read the full balloon valvuloplasty device market report here:

https://www.thebusinessresearchcompany.com/report/balloon-valvuloplasty-device-global-market-report

Which Regions Are Projected To Dominate The Balloon Valvuloplasty Device Market In The Coming Years?

North America was the largest region in the balloon valvuloplasty device market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the balloon valvuloplasty device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Balloon Valvuloplasty Device Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=17090&type=smp

Browse Through More Reports Similar to the Global Balloon Valvuloplasty Device Market 2026, By The Business Research Company

Angioplasty Balloons Market Report 2026

https://www.thebusinessresearchcompany.com/report/angioplasty-balloons-global-market-report

Biopsy Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report

Pta Balloon Catheter Market Report 2026

https://www.thebusinessresearchcompany.com/report/pta-balloon-catheter-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795